SERTRALINE HCL FORM II

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

82 API Suppliers, 27 USDMF, 27 CEP/COS, 7 JDMF, 19 EU WC, 17 KDMF, 18 NDC API, 36 Listed Suppliers

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

747 FDF Dossiers, 108 FDA Orange Book, 427 Europe, 57 Canada, 68 Australia, 25 South Africa, 62 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 SPI Pharma, 6 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 23 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 1 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 21 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 27 Solubilizers, 27 Direct Compression, 26 Controlled & Modified Release, 26 Disintegrants & Superdisintegrants, 25 Granulation, 22 Thickeners and Stabilizers, 21 Topical, 19 Film Formers & Plasticizers, 17 Parenteral, 16 Lubricants & Glidants, 14 Co-Processed Excipients, 9 API Stability Enhancers, 8 Taste Masking, 8 Emulsifying Agents, 7 Chewable & Orodispersible Aids, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 37 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 107 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

21 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 14 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

Xls

Filters

SERTRALINE HCL FORM II

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

AMWC Asia-TDAC

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

AMWC Asia-TDAC

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for SERTRALINE HCL FORM II? Find Coloring Agents used in SERTRALINE HCL FORM II to address drug delivery challenges on PharmaCompass.

SERTRALINE HCL FORM II

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

82 API Suppliers

27 USDMF

27 CEP/COS

7 JDMF

19 EU WC

17 KDMF

18 NDC API

36 Listed Suppliers

DEVELOPMENTS

28 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

747 FDF Dossiers

108 FDA Orange Book

427 Europe

57 Canada

68 Australia

25 South Africa

62 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE

TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 25MG BASE

TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 SPI Pharma

6 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

3 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

23 BASF

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

12 Gangwal Chemicals

1 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

4 Ingredion Pharma Solutions

1 JJ Chemicals

21 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

TABLET;ORAL - EQ 150MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 200MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons